Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Mashup Score: 1

OncLive

The CAR T-cell therapy ciltacabtagene autoleucel has emerged as a potentially durable treatment strategy for patients with relapsed/refractory multiple myeloma who have progressed on